questionsmedicales.fr
Lipides
Acides gras
Acides gras insaturés
Acides gras indispensables
Acides gras indispensables : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Acides gras indispensables : Questions médicales les plus fréquentes",
"headline": "Acides gras indispensables : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Acides gras indispensables : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-17",
"dateModified": "2025-05-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Acides gras indispensables"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Acides gras insaturés",
"url": "https://questionsmedicales.fr/mesh/D005231",
"about": {
"@type": "MedicalCondition",
"name": "Acides gras insaturés",
"code": {
"@type": "MedicalCode",
"code": "D005231",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acides arachidoniques",
"alternateName": "Arachidonic Acids",
"url": "https://questionsmedicales.fr/mesh/D001095",
"about": {
"@type": "MedicalCondition",
"name": "Acides arachidoniques",
"code": {
"@type": "MedicalCode",
"code": "D001095",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acide arachidonique",
"alternateName": "Arachidonic Acid",
"url": "https://questionsmedicales.fr/mesh/D016718",
"about": {
"@type": "MedicalCondition",
"name": "Acide arachidonique",
"code": {
"@type": "MedicalCode",
"code": "D016718",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Acide hydroxyeïcosatétraénoïque",
"alternateName": "Hydroxyeicosatetraenoic Acids",
"url": "https://questionsmedicales.fr/mesh/D006893",
"about": {
"@type": "MedicalCondition",
"name": "Acide hydroxyeïcosatétraénoïque",
"code": {
"@type": "MedicalCode",
"code": "D006893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.550"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acide éicosatétraénoïque-5,8,10,14 hydroxy-12",
"alternateName": "12-Hydroxy-5,8,10,14-eicosatetraenoic Acid",
"url": "https://questionsmedicales.fr/mesh/D019377",
"about": {
"@type": "MedicalCondition",
"name": "Acide éicosatétraénoïque-5,8,10,14 hydroxy-12",
"code": {
"@type": "MedicalCode",
"code": "D019377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.550.425"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Acide éicosatétraénoïque-5,8,10,14 hydroxy-12",
"alternateName": "12-Hydroxy-5,8,10,14-eicosatetraenoic Acid",
"url": "https://questionsmedicales.fr/mesh/D019377",
"about": {
"@type": "MedicalCondition",
"name": "Acide éicosatétraénoïque-5,8,10,14 hydroxy-12",
"code": {
"@type": "MedicalCode",
"code": "D019377",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.550.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thromboxanes",
"alternateName": "Thromboxanes",
"url": "https://questionsmedicales.fr/mesh/D013931",
"about": {
"@type": "MedicalCondition",
"name": "Thromboxanes",
"code": {
"@type": "MedicalCode",
"code": "D013931",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.971"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thromboxane A2",
"alternateName": "Thromboxane A2",
"url": "https://questionsmedicales.fr/mesh/D013928",
"about": {
"@type": "MedicalCondition",
"name": "Thromboxane A2",
"code": {
"@type": "MedicalCode",
"code": "D013928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.971.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thromboxane B2",
"alternateName": "Thromboxane B2",
"url": "https://questionsmedicales.fr/mesh/D013929",
"about": {
"@type": "MedicalCondition",
"name": "Thromboxane B2",
"code": {
"@type": "MedicalCode",
"code": "D013929",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.971.810"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thromboxane A2",
"alternateName": "Thromboxane A2",
"url": "https://questionsmedicales.fr/mesh/D013928",
"about": {
"@type": "MedicalCondition",
"name": "Thromboxane A2",
"code": {
"@type": "MedicalCode",
"code": "D013928",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.971.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thromboxane B2",
"alternateName": "Thromboxane B2",
"url": "https://questionsmedicales.fr/mesh/D013929",
"about": {
"@type": "MedicalCondition",
"name": "Thromboxane B2",
"code": {
"@type": "MedicalCode",
"code": "D013929",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.166.971.810"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Acides linoléniques",
"alternateName": "Linolenic Acids",
"url": "https://questionsmedicales.fr/mesh/D008042",
"about": {
"@type": "MedicalCondition",
"name": "Acides linoléniques",
"code": {
"@type": "MedicalCode",
"code": "D008042",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D10.251.355.310.640"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Acides gras indispensables",
"alternateName": "Fatty Acids, Essential",
"code": {
"@type": "MedicalCode",
"code": "D005228",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Undurti N Das",
"url": "https://questionsmedicales.fr/author/Undurti%20N%20Das",
"affiliation": {
"@type": "Organization",
"name": "UND Life Sciences, 2221 NW 5th St, Battle Ground, WA, 98604, USA. undurti@hotmail.com."
}
},
{
"@type": "Person",
"name": "A Tuchscherer",
"url": "https://questionsmedicales.fr/author/A%20Tuchscherer",
"affiliation": {
"@type": "Organization",
"name": "Leibniz Institute for Farm Animal Biology (FBN), 18196 Dummerstorf, Germany."
}
},
{
"@type": "Person",
"name": "A Tröscher",
"url": "https://questionsmedicales.fr/author/A%20Tr%C3%B6scher",
"affiliation": {
"@type": "Organization",
"name": "BASF SE, 68623 Lampertheim, Germany."
}
},
{
"@type": "Person",
"name": "H M Hammon",
"url": "https://questionsmedicales.fr/author/H%20M%20Hammon",
"affiliation": {
"@type": "Organization",
"name": "Leibniz Institute for Farm Animal Biology (FBN), 18196 Dummerstorf, Germany. Electronic address: hammon@fbn-dummerstorf.de."
}
},
{
"@type": "Person",
"name": "Nirajan Shrestha",
"url": "https://questionsmedicales.fr/author/Nirajan%20Shrestha",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy and Medical Sciences, Griffith University, Southport, QLD 4215, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Proteomic profiling reveals KRT6C as a probable hereterodimer partner for KRT9: New insights into re-classifying epidermolytic palmoplantar keratoderma (EPPK) and a milder form of pachyonychia congenita (PC-K6c) as a group of genetic cutaneous disorders.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37467889",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jprot.2023.104971"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.",
"datePublished": "2024-03-08",
"url": "https://questionsmedicales.fr/article/38462018",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijrobp.2024.02.021"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.",
"datePublished": "2024-05-07",
"url": "https://questionsmedicales.fr/article/38774215",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fphar.2024.1336347"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.",
"datePublished": "2023-03-29",
"url": "https://questionsmedicales.fr/article/37034700",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1101/2023.03.24.23287710"
}
},
{
"@type": "ScholarlyArticle",
"name": "Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).",
"datePublished": "2022-07-01",
"url": "https://questionsmedicales.fr/article/35834254",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamanetworkopen.2022.20680"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Lipides",
"item": "https://questionsmedicales.fr/mesh/D008055"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides gras",
"item": "https://questionsmedicales.fr/mesh/D005227"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides gras insaturés",
"item": "https://questionsmedicales.fr/mesh/D005231"
},
{
"@type": "ListItem",
"position": 5,
"name": "Acides gras indispensables",
"item": "https://questionsmedicales.fr/mesh/D005228"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Acides gras indispensables - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Acides gras indispensables",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Acides gras indispensables",
"description": "Comment diagnostiquer une carence en acides gras essentiels ?\nQuels tests sont utilisés pour évaluer les acides gras ?\nQuels symptômes indiquent une carence en acides gras ?\nLes tests génétiques sont-ils utiles pour les acides gras ?\nComment évaluer l'apport alimentaire en acides gras ?",
"url": "https://questionsmedicales.fr/mesh/D005228?mesh_terms=Probability&page=273#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Acides gras indispensables",
"description": "Quels sont les signes d'une carence en acides gras ?\nLes troubles de l'humeur sont-ils liés aux acides gras ?\nComment la peau réagit-elle à une carence en acides gras ?\nLes douleurs articulaires peuvent-elles être liées aux acides gras ?\nLes problèmes de mémoire sont-ils liés aux acides gras ?",
"url": "https://questionsmedicales.fr/mesh/D005228?mesh_terms=Probability&page=273#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Acides gras indispensables",
"description": "Comment prévenir une carence en acides gras ?\nQuels conseils diététiques pour les acides gras ?\nLes végétariens peuvent-ils obtenir des acides gras ?\nLes enfants ont-ils des besoins spécifiques en acides gras ?\nLes femmes enceintes doivent-elles surveiller leur apport ?",
"url": "https://questionsmedicales.fr/mesh/D005228?mesh_terms=Probability&page=273#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Acides gras indispensables",
"description": "Comment traiter une carence en acides gras ?\nQuels aliments sont riches en acides gras essentiels ?\nLes huiles végétales aident-elles à combler les carences ?\nLes suppléments d'oméga-3 sont-ils efficaces ?\nLes traitements varient-ils selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D005228?mesh_terms=Probability&page=273#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Acides gras indispensables",
"description": "Quelles complications peuvent survenir avec une carence ?\nUne carence peut-elle affecter le système immunitaire ?\nLes maladies cardiovasculaires sont-elles liées aux acides gras ?\nLes troubles de la vision peuvent-ils être causés par une carence ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D005228?mesh_terms=Probability&page=273#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Acides gras indispensables",
"description": "Quels sont les facteurs de risque de carence en acides gras ?\nLes personnes âgées sont-elles plus à risque ?\nLes régimes végétaliens présentent-ils des risques ?\nLes maladies digestives augmentent-elles le risque ?\nLe stress peut-il influencer les besoins en acides gras ?",
"url": "https://questionsmedicales.fr/mesh/D005228?mesh_terms=Probability&page=273#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une carence en acides gras essentiels ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des analyses sanguines et l'évaluation des symptômes cliniques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les acides gras ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux d'acides gras dans les lipides sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une carence en acides gras ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, peau sèche, et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les acides gras ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent aider à identifier des troubles métaboliques affectant les acides gras."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'apport alimentaire en acides gras ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un journal alimentaire peut être utilisé pour évaluer l'apport en acides gras."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une carence en acides gras ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent peau squameuse, fatigue, et troubles de la concentration."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés aux acides gras ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut contribuer à des troubles de l'humeur comme la dépression."
}
},
{
"@type": "Question",
"name": "Comment la peau réagit-elle à une carence en acides gras ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La peau peut devenir sèche, squameuse et sujette aux infections."
}
},
{
"@type": "Question",
"name": "Les douleurs articulaires peuvent-elles être liées aux acides gras ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut exacerber l'inflammation et les douleurs articulaires."
}
},
{
"@type": "Question",
"name": "Les problèmes de mémoire sont-ils liés aux acides gras ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une carence en acides gras essentiels peut affecter la mémoire et la cognition."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en acides gras ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée incluant des sources d'acides gras essentiels est clé."
}
},
{
"@type": "Question",
"name": "Quels conseils diététiques pour les acides gras ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Inclure des poissons gras, des noix et des graines dans l'alimentation quotidienne."
}
},
{
"@type": "Question",
"name": "Les végétariens peuvent-ils obtenir des acides gras ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent consommer des graines de lin, des noix et des huiles végétales."
}
},
{
"@type": "Question",
"name": "Les enfants ont-ils des besoins spécifiques en acides gras ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants ont besoin d'acides gras pour le développement cérébral et physique."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles surveiller leur apport ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un apport adéquat en acides gras est crucial pour le développement du fœtus."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en acides gras ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut des suppléments d'acides gras et une alimentation riche en oméga-3."
}
},
{
"@type": "Question",
"name": "Quels aliments sont riches en acides gras essentiels ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les poissons gras, les noix, et les graines sont de bonnes sources."
}
},
{
"@type": "Question",
"name": "Les huiles végétales aident-elles à combler les carences ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les huiles comme l'huile de lin et de colza sont riches en acides gras essentiels."
}
},
{
"@type": "Question",
"name": "Les suppléments d'oméga-3 sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont efficaces pour corriger les carences et améliorer la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon l'âge ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les besoins en acides gras peuvent varier selon l'âge et l'état de santé."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles cardiovasculaires et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Une carence peut-elle affecter le système immunitaire ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence en acides gras essentiels peut affaiblir le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les maladies cardiovasculaires sont-elles liées aux acides gras ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un déséquilibre dans les acides gras peut augmenter le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision peuvent-ils être causés par une carence ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence en acides gras essentiels peut entraîner des troubles de la vision."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut entraîner des troubles neurologiques comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de carence en acides gras ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les régimes alimentaires déséquilibrés, les maladies métaboliques et le vieillissement."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir des besoins accrus et une absorption réduite."
}
},
{
"@type": "Question",
"name": "Les régimes végétaliens présentent-ils des risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, sans planification, les régimes végétaliens peuvent manquer d'acides gras essentiels."
}
},
{
"@type": "Question",
"name": "Les maladies digestives augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies digestives peuvent affecter l'absorption des acides gras essentiels."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer les besoins en acides gras ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut augmenter les besoins en acides gras en raison de l'inflammation."
}
}
]
}
]
}
Epidermolytic palmoplantar keratoderma (EPPK), a highly penetrant autosomal dominant genodermatosis, is characterized by diffuse keratoses on palmplantar epidermis. The keratin 9 gene (KRT9) is respon...
Given the limitations of extant models for normal tissue complication probability estimation for osteoradionecrosis (ORN) of the mandible, the purpose of this study was to enrich statistical inference...
The analysis was conducted on retrospective data of 1,259 head and neck cancer (HNC) patients treated at XXX between 2005 and 2015. During a minimum 12-month post-therapy follow-up period, 173 patient...
The K-means clustering method identified six clusters among the DVHs. Based on the first five clusters, the dose-volume space was partitioned by the soft-margin SVM into distinct regions with differen...
This study presents an unsupervised-learning analysis of a large-scale data set to evaluate the risk of mandibular ORN among HNC patients. The results provide a visual risk-assessment tool for ORN (ba...
This study aimed to elucidate the therapeutic effects of Huaier granules on hepatocellular carcinoma (HCC) within the Milan criteria in patients who underwent microwave ablation (MWA)....
A total of 228 patients were included, with 97 in the Huaier group and 131 in the control group. We evaluated progression-free survival (PFS), overall survival (OS), and extrahepatic metastasis surviv...
Following PSM, the 1-, 3-, and 5-year PFS rates in the Huaier and control groups were 83.5% vs 70.7%, 57.7% vs 42.6%, and 43.6% vs 31.9% (...
Huaier granules can reduce the risk of recurrence and improve the OS of patients with HCC within the Milan criteria following MWA. Administering Huaier granules for over 6 months proved beneficial....
Given the limitations of extant models for normal tissue complication probability estimation for osteoradionecrosis (ORN) of the mandible, the purpose of this study was to enrich statistical inference...
The analysis was conducted on retrospective data of 1,259 head and neck cancer (HNC) patients treated at the University of Texas MD Anderson Cancer Center between 2005 and 2015. The (structural) clust...
The K-means clustering method identified six clusters among the DVHs. Based on the first five clusters, the dose-volume space was partitioned almost perfectly by the soft-margin SVM into distinct regi...
This study presents an unsupervised-learning analysis of a large-scale data set to evaluate the risk of mandibular ORN among HNC patients. The results provide a visual risk-assessment tool (based on t...
The cardiovascular and renal outcomes of angiotensin-II receptor blocker (ARB) and angiotensin-converting enzyme inhibitor (ACEI) treatment are well-known; however, few studies have evaluated initiati...
To emulate a target trial to evaluate the cognitive outcomes of initiating an ARB- vs ACEI-based antihypertensive regimen in individuals at risk for mild cognitive impairment (MCI) and probable dement...
Active comparator, new-user observational cohort study design using data from the Systolic Blood Pressure Intervention Trial (SPRINT), conducted November 2010 through July 2018. Marginal cause-specifi...
New users of ARB vs ACEI during the first 12 months of trial follow-up....
Composite of adjudicated amnestic MCI or PD....
Of 9361 participants, 727 and 1313 new users of an ARB or ACEI, respectively, with well-balanced baseline characteristics between medication exposure groups after inverse probability weighting (mean [...
In this observational cohort study of US adults at high cardiovascular disease risk, there was no difference in the rate of amnestic MCI or PD among new users of an ARB compared with ACEI, although 95...
Dependent censoring involves a preferential attrition of a subgroup of interest; occurring in survival analysis, it may impact interpretation by introducing a selection bias. To assess the potential b...
To assess the relationship between renal function and efficacy/safety of imipenem/cilastatin/relebactam for the treatment of hospital-acquired/ventilator-associated pneumonia (HABP/VABP) from RESTORE-...
Adults with HABP/VABP were randomized 1:1 to IV imipenem/cilastatin/relebactam 1.25 g or piperacillin/tazobactam 4.5 g every 6 h for 7-14 days. Initial doses were selected by CL...
The modified ITT population comprised those with normal renal function (...
Prescribing information-defined dose adjustments in participants with baseline RI and full dosing of imipenem/cilastatin/relebactam 1.25 g every 6 h for participants with normal renal function or augm...
To identify less invasive and easily applicable serum cytokine-derived biomarkers which contribute to the diagnostic utility and risk assessment ability of the prostate health index (PHI) based multiv...
Serum 45 cytokines screening was performed in a small training cohort consisting of 10 sera by Luminex liquid array-based multiplexed immunoassays and identified TRAIL and IL-10 as new biomarkers for ...
TRAIL and IL-10 were identified as potential serum biomarkers for AG PCa detection by the result of multi-cytokines screening in the univariate analysis, while multivariable logistic regression confir...
We suggest a significant advantage for the PHI-based multivariate combinations of serum TRAIL and IL-10 comparing to PHI or other serum-derived biomarkers alone in the detection and risk stratificatio...
Switching from intravenous antibiotic therapy to oral antibiotic therapy among neonates is not yet practised in high-income settings due to uncertainties about exposure and safety. We aimed to assess ...
In this multicentre, randomised, open-label, non-inferiority trial, patients were recruited at 17 hospitals in the Netherlands. Neonates (postmenstrual age ≥35 weeks, postnatal age 0-28 days, bodyweig...
Between Feb 8, 2018 and May 12, 2021, 510 neonates were randomly assigned (n=255 oral amoxicillin-clavulanic group; n=255 intravenous antibiotic group). After excluding those who withdrew consent (n=4...
An early intravenous-to-oral antibiotic switch with amoxicillin-clavulanic acid is non-inferior to a full course of intravenous antibiotics in neonates with probable bacterial infection and is not ass...
The Netherlands Organization for Health Research and Development, Innovatiefonds Zorgverzekeraars, and the Sophia Foundation for Scientific Research....
This paper draws on a qualitative interview-based study that explored online mental health and wellbeing interventions and services for care-experienced young people. The study involved young people (...